Gennova Biopharmaceuticals ready with 70 lakh vaccine dosages

June 29, 2022 18:25

A swab is taken for testing for Covid

Gennova Biopharmaceuticals Ltd on Wednesday said it is ready with 70 lakh dosages of its Gemcovac-19 vaccine, the first indigenously developed mRNA vaccine against COVID-19 to be approved for restricted emergency use in adults.

The company, which is a subsidiary of Emcure Pharmaceuticals Ltd, has an annual capacity of producing 200 million dosages of the vaccine and is awaiting the government's nod to roll it out in the market.

Gemcovac-19 had received Emergency Use Authorization (EUA) from the Drugs Controller General of India (DCGI) on Tuesday.

Addressing a virtual press conference, Gennova Biopharmaceuticals Ltd, Chief Operating Officer Samit Mehta said Gemcovac-19 is the first mRNA vaccine developed in India and only third mRNA vaccine to be approved for COVID-19 in the world.

In contrast to other mRNA vaccines that require to be stored at sub-zero temperatures, Gemcovac-19 can be stored at 2-8 degrees. That makes it "unique in its deployability in countries like India" and other similar nations, Mehta said, highlighting the advantages of Gemcovac-19 in terms of logistics and transportation. -- PTI

« Back to LIVE

TOP STORIES

Should Dhoni bat higher up the order?

West Indies batting great Brian Lara believes CSK's Mahendra Singh Dhoni won't consider a promotion in the batting order.

Can Gukesh maintain lead in Candidates' Chess?

Gukesh to clash with Alireza on what promises to be a photo finish

Struggling Punjab Kings, Gujarat Titans in battle of cellar teams

Their campaigns wobbling after a string of defeats, bottom-rung teams Punjab Kings and Gujarat Titans will be desperate to arrest the slide and get back to winning ways in their Indian Premier League match in Mullanpur on Sunday.

It's perform or perish time for RCB against KKR

With five consecutive defeats, bottom-placed RCB have the daunting task of winning their remaining seven games to keep their play-off prospects alive.

Kejriwal being pushed towards 'slow death' in Tihar: AAP

Kejriwal, who has Type-2 diabetes, has been asking for insulin and a video conferencing with his family doctor but his requests are being denied by the jail administration, party spokesperson Saurabh Bharadwaj said in a press conference.